INM-089 IVT formulation selected for continued developmentDemonstrated successful delivery at doses up to 10 times the projected therapeutic level, indicating a favorable pharmacokinetic profile and a ...

Ocular drug delivery presents one of the greatest challenges in pharmaceutical science, largely due to the eye’s unique anatomy, which limits drug ... for prevalent eye diseases like age-related ...

Macular degeneration is one of the leading causes of vision loss, affecting millions worldwide, especially those over 60.

Our eyesight is essential to getting around, but if you’re not careful it can be seriously challenged by age-related macular degeneration.

Macular degeneration is a leading cause of vision loss for people over 50, but there are ways to help protect your eyesight.

A large study that retrospectively analyzed the visual outcomes and rate of development of neovascular age-related macular ...

The Gonzales Lab at UNR Med, led by Albert Gonzales, Ph.D., assistant professor of physiology and cell biology, spearheaded ...

The following is a summary of “Evaluation of macular retinal oximetry across different levels of diabetic retinopathy: a cross sectional study,” published in the January 2025 issue of Ophthalmology by ...

The Delhi motor show earlier this month was witness to a flurry of models in the premium end of the market across powertrain options—diesel, electric and hybrid. Rising demand for premium ...

OpenAI just released o3-mini, a reasoning model that’s faster, cheaper, and more accurate than its predecessor. On Thursday, Microsoft announced that it’s rolling OpenAI's reasoning model o1 ...

Jan. 14, 2025 — Age-related macular degeneration (AMD), which affects about 200 million people worldwide and can result in legal blindness, impairs an area of the eye (retina) used for reading ...